Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

Villasante-Tezanos A. G.; Rohde C.; Nielsen J.; de Leon J.

首页> 外文期刊>Acta Psychiatrica Scandinavica >Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

【24h】

Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

机译：肺炎风险：大约三分之一是由于氯氮平，三分之二是由于治疗抗性精神分裂症

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Acta Psychiatrica Scandinavica》 |2020年第1期|共2页
作者
Villasante-Tezanos A. G.; Rohde C.; Nielsen J.; de Leon J.;
展开▼
作者单位

Univ Kentucky Dept Stat Lexington KY USA;

Aarhus Univ Hosp Psychiat Dept Affect Disorders Aarhus Denmark;

Copenhagen Univ Hosp Mental Hlth Ctr Glostrup Copenhagen Denmark;

Eastern State Hosp Mental Hlth Res Ctr Lexington KY 40511 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
clozapine; adverse effects; clozapine; toxicity; infection; pneumonia; respiratory aspiration;

机译：氯氮平;不利影响;氯氮平;毒性;感染;肺炎;呼吸抱负;

相似文献

外文文献
中文文献
专利

1. Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia [J] . Villasante-Tezanos A. G., Rohde C., Nielsen J., Acta Psychiatrica Scandinavica . 2020,第1期

机译：肺炎风险：大约三分之一是由于氯氮平，三分之二是由于治疗抗性精神分裂症
2. Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine A Nationwide Cohort Study [J] . Wu Chi-Shin, Chen Tien-Yu, Tsai Shang-Ying, Journal of clinical psychopharmacology . 2019,第4期

机译：估算精神分裂症患者肺炎的风险新接受克罗泽普综合研究
3. Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study [J] . Nobuyuki Nomura, Kohei Kitagawa, Ryuhei So, Therapeutic advances in psychopharmacology. . 2021,第a期

机译：治疗抗性精神分裂症患者副作用与氯氮平接触的综合评估：人口药代动力学研究
4. Influence of a genetic signature on therapeutic effects of clozapine in schizophrenia subjects from South China [C] . Gong Daoyuan, Li Ziping, Li Bo, IT in Medicine and Education (ITME), 2011 International Symposium on . 2011

机译：基因签名对氯氮平对华南地区精神分裂症患者治疗作用的影响
5. Pharmacogenetic analysis of dopamine and glutamate receptor gene polymorphisms and clinical response to clozapine in patients with schizophrenia [D] . Hwang, Rudi 2014

机译：精神分裂症患者多巴胺和谷氨酸受体基因多态性的药理学分析和对氯氮平的临床反应
6. Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia [O] . Yuka Sugawara Kikuchi, Takashi Kanbayashi, Tetsuo Shimizu 1987

机译：难治性精神分裂症患者氯氮平所致脑电图异常与血清氯氮平浓度的关系
7. S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA [O] . Kee Jeong Park, Hyo-Won Kim 2020

机译：S194。抗治疗性精神分裂症的青少年氯氮平和电耦合治疗增强

Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia

著录项

相似文献

相关主题

期刊订阅